| Time After Starting | Time After Stopping | ALT* (U/L) | Bilirubin (mg/dL) | Other |
|---|---|---|---|---|
| 0 | 38 | 0.7 | Tamoxifen started | |
| 4 weeks | 35 | 0.9 | ||
| 10 weeks | 54 | 0.9 | Symptoms (nausea) | |
| 14 weeks | 0 | 735 | 4.1 | Worsening symptoms |
| 15 weeks | 1 week | 670 | 5.3 | |
| 16 weeks | 2 weeks | 110 | 3.5 | |
| 19 weeks | 5 weeks | 54 | 1.0 | Nausea resolved |
| 21 weeks | 7 weeks | 50 | 1.4 | |
| Time After restarting | Time After Stopping | Tamoxifen restarted | ||
| 1 week | 0 | 79 | 1.1 | Symptoms (nausea) |
| 2 weeks | 1 week | 258 | 1.8 | |
| 3 weeks | 2 weeks | 180 | 1.3 | |
| 5 weeks | 4 weeks | 64 | 1.2 | |
| Normal Values | <45 | <1.2 | ||
Values estimated from Figure.
From: Tamoxifen
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.